199 related articles for article (PubMed ID: 35720504)
1. LIMK1: A promising prognostic and immune infiltration indicator in colorectal cancer.
Liu X; Song Q; Wang D; Liu Y; Zhang Z; Fu W
Oncol Lett; 2022 Jul; 24(1):234. PubMed ID: 35720504
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of LIMK1 Is Correlated With Poor Prognosis and Immune Infiltrates in Lung Adenocarcinoma.
Lu G; Zhou Y; Zhang C; Zhang Y
Front Genet; 2021; 12():671585. PubMed ID: 34149814
[TBL] [Abstract][Full Text] [Related]
3. Colorectal cancer with low SLC35A3 is associated with immune infiltrates and poor prognosis.
Lu S; Sun X; Tang H; Yu J; Wang B; Xiao R; Qu J; Sun F; Deng Z; Li C; Yang P; Yang Z; Rao B
Sci Rep; 2024 Jan; 14(1):329. PubMed ID: 38172565
[TBL] [Abstract][Full Text] [Related]
4. Cofilin-1, LIMK1 and SSH1 are differentially expressed in locally advanced colorectal cancer and according to consensus molecular subtypes.
Sousa-Squiavinato ACM; Vasconcelos RI; Gehren AS; Fernandes PV; de Oliveira IM; Boroni M; Morgado-Díaz JA
Cancer Cell Int; 2021 Jan; 21(1):69. PubMed ID: 33482809
[TBL] [Abstract][Full Text] [Related]
5. Mapk14 is a Prognostic Biomarker and Correlates with the Clinicopathological Features and Immune Infiltration of Colorectal Cancer.
Wang D; Peng L; Hua L; Li J; Liu Y; Zhou Y
Front Cell Dev Biol; 2022; 10():817800. PubMed ID: 35141222
[No Abstract] [Full Text] [Related]
6. Upregulated GSDMB in Clear Cell Renal Cell Carcinoma Is Associated with Immune Infiltrates and Poor Prognosis.
Cui Y; Zhou Z; Chai Y; Zhang Y
J Immunol Res; 2021; 2021():7753553. PubMed ID: 34957313
[TBL] [Abstract][Full Text] [Related]
7. SEMA6B Overexpression Predicts Poor Prognosis and Correlates With the Tumor Immunosuppressive Microenvironment in Colorectal Cancer.
Li T; Yan Z; Wang W; Zhang R; Gan W; Lv S; Zeng Z; Hou Y; Yang M
Front Mol Biosci; 2021; 8():687319. PubMed ID: 34938771
[No Abstract] [Full Text] [Related]
8. CCDC134 as a Prognostic-Related Biomarker in Breast Cancer Correlating With Immune Infiltrates.
Huang Z; Yang L; Chen J; Li S; Huang J; Chen Y; Liu J; Wang H; Yu H
Front Oncol; 2022; 12():858487. PubMed ID: 35311121
[TBL] [Abstract][Full Text] [Related]
9. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
[TBL] [Abstract][Full Text] [Related]
10. High Expression Level of TRIP6 is Correlated with Poor Prognosis in Colorectal Cancer and Promotes Tumor Cell Proliferation and Migration.
Ren H; Su Z; Yang J; Cao J; Zhang Y; Sheng K; Guo K; Wang Y
Biochem Genet; 2024 Mar; ():. PubMed ID: 38430448
[TBL] [Abstract][Full Text] [Related]
11. Decreased E2F2 Expression Correlates with Poor Prognosis and Immune Infiltrates in Patients with Colorectal Cancer.
Shang Y; Zhang Y; Liu J; Chen L; Yang X; Zhu Z; Li D; Deng Y; Zhou Z; Lu B; Fu CG
J Cancer; 2022; 13(2):653-668. PubMed ID: 35069909
[TBL] [Abstract][Full Text] [Related]
12. BICDL1 Predicts Poor Prognosis and is Correlated with Methylation and Immune Infiltration in Colorectal Cancer.
Luo H; Luo J; Ding N; Zhang T; He Y
Pharmgenomics Pers Med; 2023; 16():1109-1126. PubMed ID: 38149287
[TBL] [Abstract][Full Text] [Related]
13. Construction of a Novel Immune-Related mRNA Signature to Predict the Prognosis and Immune Characteristics of Human Colorectal Cancer.
Li J; Han T; Wang X; Wang Y; Chen X; Chen W; Yang Q
Front Genet; 2022; 13():851373. PubMed ID: 35401707
[No Abstract] [Full Text] [Related]
14. SLC2A1 is a Diagnostic Biomarker Involved in Immune Infiltration of Colorectal Cancer and Associated With m6A Modification and ceRNA.
Liu XS; Yang JW; Zeng J; Chen XQ; Gao Y; Kui XY; Liu XY; Zhang Y; Zhang YH; Pei ZJ
Front Cell Dev Biol; 2022; 10():853596. PubMed ID: 35399515
[No Abstract] [Full Text] [Related]
15. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
[TBL] [Abstract][Full Text] [Related]
16. A Prognostic Model Using Immune-Related Genes for Colorectal Cancer.
Feng W; Zhang Y; Liu W; Wang X; Lei T; Yuan Y; Chen Z; Song W
Front Cell Dev Biol; 2022; 10():813043. PubMed ID: 35252182
[TBL] [Abstract][Full Text] [Related]
17. LIM kinase 1 interacts with myosin-9 and alpha-actinin-4 and promotes colorectal cancer progression.
Liao Q; Li R; Zhou R; Pan Z; Xu L; Ding Y; Zhao L
Br J Cancer; 2017 Aug; 117(4):563-571. PubMed ID: 28664914
[TBL] [Abstract][Full Text] [Related]
18. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
[TBL] [Abstract][Full Text] [Related]
19. CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer.
Yue Y; Zhang Q; Sun Z
Front Immunol; 2021; 12():758040. PubMed ID: 35140706
[TBL] [Abstract][Full Text] [Related]
20. Predicting the Survival and Immune Landscape of Colorectal Cancer Patients Using an Immune-Related lncRNA Pair Model.
Ma C; Zhang X; Zhao X; Zhang N; Zhou S; Zhang Y; Li P
Front Genet; 2021; 12():690530. PubMed ID: 34552614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
